NA
MEDP icon

NewEdge Advisors’s Medpace MEDP Stock Holding History

NewEdge Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.32M Buy
2,757
+853
+45% +$437K ﹤0.01% 1335
2025
Q4 		$1.07M Buy
1,904
+575
+43% +$326K ﹤0.01% 1447
2025
Q3 		$683K Buy
1,329
+208
+19% +$90.8K ﹤0.01% 1630
2025
Q2 		$352K Buy
1,121
+73
+7% +$21.9K ﹤0.01% 1919
2025
Q1 		$319K Buy
1,048
+190
+22% +$63.9K ﹤0.01% 1859
2024
Q4 		$285K Sell
858
-498
-37% -$169K ﹤0.01% 1906
2024
Q3 		$453K Sell
1,356
-343
-20% -$130K ﹤0.01% 1532
2024
Q2 		$700K Sell
1,699
-376
-18% -$149K 0.01% 1229
2024
Q1 		$839K Sell
2,075
-61
-3% -$21.4K 0.01% 1086
2023
Q4 		$644K Buy
2,136
+557
+35% +$150K 0.01% 1156
2023
Q3 		$382K Sell
1,579
-2,676
-63% -$684K ﹤0.01% 1303
2023
Q2 		$1.02M Buy
4,255
+3,747
+738% +$778K 0.01% 857
2023
Q1 		$95.5K Sell
508
-209
-29% -$43.2K ﹤0.01% 1763
2022
Q4 		$4.4K Sell
717
-4,409
-86% -$881K ﹤0.01% 2636
2022
Q3 		$806K Buy
+5,126
New +$818K 0.01% 738

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

NewEdge Advisors's MEDP Position: Q1 2026 in Review

NewEdge Advisors increased its Medpace (MEDP) stake by 45% in Q1 2026, buying an estimated $437K and bringing the position to 2,757 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1335.

NewEdge Advisors first reported a position in MEDP in Q3 2022 and has held it in 15 quarters since. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • NewEdge Advisors held 2,757 shares of Medpace worth $1.32M as of Q1 2026.
  • NewEdge Advisors bought 853 Medpace shares in Q1 2026, an estimated $437K.
  • Medpace made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #1335 holding.
  • NewEdge Advisors first reported a position in Medpace in Q3 2022 and has held it in 15 quarters since.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.